Melola Discovery

← Melola Discovery

Jurnal SINTA 1

COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?

ACTA MEDICA INDONESIANA · Vol. 53 No. 1 (2021)

ISSN
2338-2732, 0125-9326
Terbit
2021-03-31
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng

Abstrak

It has been a year since the Indonesian government announced its first COVID-19 identified in Jakarta. Since then, there have been more than 900,000 cases in Indonesia with case fatality rate (CFR) of 2.9%. The number of new cases per day is now ranging from 9,000 cases to almost 13,000 cases. Not only in Indonesia, but the number of new cases along with the mortality rate in other countries, such as Malaysia, Japan, United States, and Europe region also increased dramatically.COVID-19 vaccines are being investigated and the world hopes that vaccines will be the answer to tackle this pandemic. Is it really so? Immunization is an effort to induce immunity in individuals to prevent a disease or the complication related to the diseases that may be catastrophic. Immunization can be divided into passive, which is by giving certain type of antibody and active, which means that either we get the disease, or we get the antigen injected into our body.Having prior vaccination or past COVID-19 does not mean that someone is totally immune to COVID-19 as a recent study suggested that the antibody related to COVID-19 past infection is significantly decreasing after 3 months post-infection. Compliance to implementation of health protocol remained the most crucial strategy during this pandemic.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 277 tautan kepenulisan bersama · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Institut Agama Islam Negeri Bone
  • Hasanuddin University
  • University of Indonesia
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Kuntjoro HarimurtiAfiliasi tidak diketahui14
Muhammad Khifzhon AzwarAfiliasi tidak diketahui8
Rahmi IstantiAfiliasi tidak diketahui8
Noto DwimartutieAfiliasi tidak diketahui7
Hamzah ShatriAfiliasi tidak diketahui7
Roza MulyanaAfiliasi tidak diketahui6
Rensa RensaAfiliasi tidak diketahui6
Eka Dian SafitriAfiliasi tidak diketahui6
Siti Rizny F SaldiAfiliasi tidak diketahui6
Ikhwan RinaldiAfiliasi tidak diketahui5
Cleopas Martin RumendeAfiliasi tidak diketahui5
Rudi PutrantoAfiliasi tidak diketahui5
Muhammad K AzwarAfiliasi tidak diketahui5
Nur RiviatiAfiliasi tidak diketahui4
Aulia RizkaAfiliasi tidak diketahui4
Ari Fahrial SyamAfiliasi tidak diketahui4
Eric Daniel TendaAfiliasi tidak diketahui4
Sri SunartiAfiliasi tidak diketahui4
Fatichati BudiningsihAfiliasi tidak diketahui4
Lazuardhi DwipaAfiliasi tidak diketahui4
Agus SudarsoAfiliasi tidak diketahui4
Purwita W LaksmiAfiliasi tidak diketahui3
Tirza Z TaminAfiliasi tidak diketahui3
Rudy HidayatAfiliasi tidak diketahui3
Dyah PurnamasariAfiliasi tidak diketahui3
Esthika DewiastyAfiliasi tidak diketahui3
Muhammad YaminInstitut Agama Islam Negeri Bone3
Simon SalimAfiliasi tidak diketahui3
Ika FitrianaHasanuddin University3
Imam SubektiAfiliasi tidak diketahui3
I Gusti Putu Suka AryanaAfiliasi tidak diketahui3
Yudo Murti MupangatiAfiliasi tidak diketahui3
Harry IsbagioAfiliasi tidak diketahui2
Bambang SetyohadiAfiliasi tidak diketahui2
Cleopas M RumendeAfiliasi tidak diketahui2
Em YunirUniversity of Indonesia2
Dharmeizar DharmeizarAfiliasi tidak diketahui2
Ika Prasetya WijayaAfiliasi tidak diketahui2

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc) 
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?</dc:title>
	<dc:creator>Setiati, Siti</dc:creator>
	<dc:creator>Marsigit, Jessica</dc:creator>
	<dc:subject xml:lang="en-US">COVID-19</dc:subject>
	<dc:subject xml:lang="en-US">vaccine</dc:subject>
	<dc:subject xml:lang="en-US">elderly</dc:subject>
	<dc:subject xml:lang="en-US">COVID-19 vaccine</dc:subject>
	<dc:description xml:lang="en-US">It has been a year since the Indonesian government announced its first COVID-19 identified in Jakarta. Since then, there have been more than 900,000 cases in Indonesia with case fatality rate (CFR) of 2.9%. The number of new cases per day is now ranging from 9,000 cases to almost 13,000 cases. Not only in Indonesia, but the number of new cases along with the mortality rate in other countries, such as Malaysia, Japan, United States, and Europe region also increased dramatically.COVID-19 vaccines are being investigated and the world hopes that vaccines will be the answer to tackle this pandemic. Is it really so? Immunization is an effort to induce immunity in individuals to prevent a disease or the complication related to the diseases that may be catastrophic. Immunization can be divided into passive, which is by giving certain type of antibody and active, which means that either we get the disease, or we get the antigen injected into our body.Having prior vaccination or past COVID-19 does not mean that someone is totally immune to COVID-19 as a recent study suggested that the antibody related to COVID-19 past infection is significantly decreasing after 3 months post-infection. Compliance to implementation of health protocol remained the most crucial strategy during this pandemic.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2021-03-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/1766</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 53 No. 1 (2021): Acta Medica Indonesiana; 1</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/1766/482</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Acta Medica Indonesiana</dc:rights>
</oai_dc:dc>